Former CDC head lands vaccine job at Merck

WASHINGTON Mon Dec 21, 2009 1:53pm EST

Julie Gerberding speaks during an interview with Reuters in Washington, February 1, 2008. REUTERS/Hyungwon Kang

Julie Gerberding speaks during an interview with Reuters in Washington, February 1, 2008.

Credit: Reuters/Hyungwon Kang

Related Topics

WASHINGTON (Reuters) - Dr. Julie Gerberding, former director of the Centers for Disease Control and Prevention, was named president of Merck & Co Inc's vaccine division, the company said on Monday.

Gerberding, who led the CDC from 2002 to 2009, stepped down when President Barack Obama took office.

She had led the agency from one crisis to another, including the investigation into the anthrax attacks that killed five people in 2001, the H5N1 avian influenza, the global outbreak of severe acute respiratory syndrome, or SARS, and various outbreaks of food poisoning.

"As a preeminent authority in public health, infectious diseases and vaccines, Dr. Gerberding is the ideal choice to lead Merck's engagement with organizations around the world that share our commitment to the use of vaccines to prevent disease and save lives," Merck Chief Executive Officer Richard Clark said in a statement.

"I am very excited to be joining Merck where I can help to expand access to vaccines around the world," added Gerberding, who will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia.

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see
Comments (2)
nicewoman wrote:
Seems incredibly suspicious to me. Five BILLION dollar company… suddenly headed up by an organization that tells you to either vaccinate or not and the risks therein. Would be pretty easy to push whatever filled your pockets. If I had the authority, I’d investigate this situation pronto.

12월 21, 2009 8:44pm EST  --  Report as abuse
greenone wrote:
So Gerberding cashes in. No surprise, this is the climate that pervades government agencies and the corporations they regulate. Gerberding was a good friend to Merck. It bears asking, however, with all the cases implicating Merck in fraudulent activity, how is it that Gerberding now feels comfortable joining the Merck team? The losers in this revolving-door practice are Americans who still trust their health to a 6th-grade concept of democracy and accountability.

12월 22, 2009 12:16am EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.